APPLICATIONS OF MONOCLONAL-ANTIBODIES IN CLINICAL ONCOLOGY

被引：17

作者：

GEORGE, AJT ^{[1
]}

SPOONER, RA ^{[1
]}

EPENETOS, AA ^{[1
]}

机构：

[1] HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,IMPERIAL CANC RES FUND,TUMOUR TARGETING LAB,LONDON W12 0NN,ENGLAND

来源：

IMMUNOLOGY TODAY | 1994年 / 15卷 / 12期

关键词：

D O I：

10.1016/0167-5699(94)90216-X

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Application of monoclonal antibodies (MAbs) to clinical settings has proved to be slower than originally hoped. However, a recent conference* provided evidence that the field is coming of age, and that antibodies, and their recombinant derivatives, will continue to find a role in the clinic.

引用

页码：559 / 561

页数：3